Biogen

Biogen

Team Size
1–10
Employees
MedCity News

Biogen fends off Mylan’s challenge to patent on top-selling multiple sclerosis drug

Xconomy

Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer

the home of AI info

Reviewing Biogen Inc. (BIIB)'s and Minerva Neurosciences Inc. (NASDAQ:NERV)'s results

Xconomy

3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug

Xconomy

Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results

Quartz

Biogen’s latest Alzheimer’s drug trials will change dementia drug research

Xconomy

As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug

Xconomy

Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study

Xconomy

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More

PrivateEquityWire

Ancala Partners portfolio company Biogen acquires anaerobic digestion plant in South-West England

Xconomy

Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis

Xconomy

Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More

Xconomy

Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO

Xconomy

Bio Roundup: Pelosi's Reveal, Alder's Deal, Biogen's Fails & More

Xconomy

BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage

MedCity News

Biogen, Alkermes MS drug bests Biogen's soon-to-be-generic blockbuster in Phase III study

MedCity News

Biogen spinal muscular atrophy drug shows strong data in long-term follow-up

Reuters Top News

NHS England, Biogen reach deal on pricey drug for deadly disorder

Xconomy

Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More

Xconomy

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More